CISATRACURIUM MYLAN cisatracurium (as besilate) 10 mg/5 mL solution for injection vial

Nchi: Australia

Lugha: Kiingereza

Chanzo: Department of Health (Therapeutic Goods Administration)

Viambatanisho vya kazi:

cisatracurium besilate, Quantity: 2.68 mg/mL (Equivalent: cisatracurium, Qty 2 mg/mL)

Inapatikana kutoka:

MedTAS Pty Ltd

Dawa fomu:

Injection, solution

Tungo:

Excipient Ingredients: benzenesulfonic acid; water for injections

Njia ya uendeshaji:

Intravenous Bolus, Intravenous Infusion

Vitengo katika mfuko:

5 vials

Dawa ya aina:

(S4) Prescription Only Medicine

Matibabu dalili:

Cisatracurium Mylan Injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. It is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Bidhaa muhtasari:

Visual Identification: A colourless to pale yellow or greenish solution.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 15 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Idhini hali ya:

Registered

Idhini ya tarehe:

2022-01-19